Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obama Offers Specifics On Final Vote Timing, Follow-On Biologics

This article was originally published in The Pink Sheet Daily

Executive Summary

At a public town hall meeting in North Carolina, the President suggests late fall, lower exclusivity will feature in the conclusion of the health care debate.
Advertisement

Related Content

Kennedy Succession Plans: Implications For Health Care Reform
Kennedy Succession Plans: Implications For Health Care Reform
Teva Launching "6 vs 12" Campaign On Follow-On Biologics
Teva Launching "6 vs 12" Campaign On Follow-On Biologics
Obama Reiterates Desire To Get "Better Deal" From Drug Firms In Health Reform
Obama Reiterates Desire To Get "Better Deal" From Drug Firms In Health Reform

Topics

Advertisement
UsernamePublicRestriction

Register

PS069766

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel